FRACTIONATED REIRRADIATION OF RECURRENT IDH WILDTYPE GLIOBLASTOMA: HIGHER REIRRADIAITON DOSE AND SAFETY

被引：0
|
作者：
Lecompte, Michael [1 ]
Vuppala, Neil [2 ]
Reyes, Juan [3 ]
Page, Brandi [1 ]
Croog, Victoria [1 ]
Huang, Ellen [1 ]
Redmond, Kristin [1 ]
Kleinberg, Lawrence [1 ]
机构：
[1] Johns Hopkins Sch Med, Baltimore, MD USA
[2] Alabama Coll Osteopath Med, Dothan, AL USA
[3] Johns Hopkins Univ, Baltimore, MD USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae165.0301
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RADT-17
引用
收藏
页数：2
相关论文
共 44 条
  • [21] Dose-finding and safety study of an oncolytic polio/rhinovirus recombinant against recurrent glioblastoma.
    Desjardins, Annick
    Sampson, John Howard
    Peters, Katherine B.
    Ranjan, Tulika
    Vlahovic, Gordana
    Threatt, Stevie
    Herndon, James Emmett
    Friedman, Allan H.
    Friedman, Henry S.
    Bigner, Darell D.
    Gromeier, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Retrospective Study of the Safety and Efficacy of Anlotinib Combined With Dose-Dense Temozolomide in Patients With Recurrent Glioblastoma
    She, Lei
    Su, Lin
    Shen, Liangfang
    Liu, Chao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] REGORAFENIB IN COMBINATION WITH TEMOZOLOMIDE WITH OR WITHOUT RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED MGMT-METHYLATED, IDH WILDTYPE GLIOBLASTOMA: A PHASE I DOSE-FINDING STUDY (REGOMA-2)
    Padovan, Marta
    De Salvo, Gian Luca
    D'Avolio, Antonio
    Caccese, Mario
    Zagonel, Vittorina
    Lombardi, Giuseppe
    NEURO-ONCOLOGY, 2022, 24 : 73 - 73
  • [24] A Pilot Study of Low-dose Fractionated Radiotherapy and Chemotherapy as Second-line Treatment for Recurrent or Progressive Glioblastoma Multiform: A Final Report
    Manfrida, S.
    Diletto, B.
    Chiesa, S.
    D'Agostino, G. R.
    Chiloiro, G.
    Mantini, G.
    Fersino, S.
    Mattiucci, G. C.
    Valentini, V.
    Balducci, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S277 - S278
  • [25] LOW-DOSE FRACTIONATED RADIOTHERAPY PLUS CHEMOTHERAPY IN PATIENTS AFFECTED BY GLIOBLASTOMA MULTIFORME IN FIRST RECURRENT OR PROGRESSIVE DISEASE: INTERIM ANALYSIS.
    D' Agostino, G. R.
    Chiesa, S.
    Manfrida, S.
    Diletto, B.
    Mantini, G.
    Frascino, V.
    Micciche, F.
    Autorino, R.
    Valentini, V.
    De Rose, F.
    Anile, C.
    Balducci, M.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S328 - S328
  • [26] Phase 2, Open-Label, Trial Evaluating Safety, Tolerability, and Preliminary Antitumor Activity of Panobinostat and Fractionated Stereotactic Reirradiation Therapy for Recurrent High-Grade Gliomas
    Palmer, J. D.
    Werner-Wasik, M.
    Andrews, D. W.
    Evans, J.
    Glass, J.
    Kim, L.
    Judy, K.
    Farrell, C.
    Bar Ad, V.
    Simone, N. L.
    Dicker, A. P.
    Shi, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S109 - S110
  • [27] Safety and Efficacy of Stereotactic Body Radiation Therapy (SBRT) Reirradiation for New or Recurrent Pulmonary Malignancies Following Previous In-Field Conventionally Fractionated Thoracic Radiation Therapy (CFRT)
    Heskel, M.
    Xanthopoulos, E. P.
    Berman, A. T.
    Levin, W.
    Vachani, A.
    Haas, A.
    Sterman, D. H.
    Lanfranco, A.
    Moon, E.
    Corradetti, M. N.
    Hahn, S. M.
    Cengel, K. A.
    Rengan, R.
    Simone, C. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S20 - S21
  • [28] Safety and Efficacy of Stereotactic Body Radiation Therapy (SBRT) Reirradiation for New or Recurrent Pulmonary Malignancies Following Previous In-Field Conventionally Fractionated Thoracic Radiation Therapy (CFRT)
    Heskel, M.
    Xanthopoulos, E. P.
    Berman, A. T.
    Levin, W.
    Vachani, A.
    Haas, A.
    Sterman, D. H.
    Lanfranco, A.
    Moon, E.
    Corradetti, M. N.
    Hahn, S. M.
    Cengel, K. A.
    Rengan, R.
    Simone, C. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S625 - S625
  • [29] A phase II clinical trial evaluating the efficacy and safety of apatinib combined with dose-dense temozolomide in recurrent glioblastoma
    Wang, Y.
    Tao, R.
    ANNALS OF ONCOLOGY, 2019, 30
  • [30] PHASE II STUDY OF BEVACIZUMAB IN COMBINATION WITH DOSE-DENSE TEMOZOLOMIDE IN PATIENTS WITH RECURRENT GLIOBLASTOMA: PRELIMINARY SAFETY ANALYSIS
    Sepulveda, Juan
    Belda, Cristobal
    Balana, Carmen
    Perez Segura, Pedro
    Reynes, Gaspar
    Gil, Miquel
    Gallego, Oscar
    Berrocal, Alfonso
    NEURO-ONCOLOGY, 2011, 13 : 55 - 55
12345